STEPHANIE GRIFFIN: Open Payments
NPI 1497841977 · FORT PAYNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 19 payments from 6 companies in 2025. Trend: 2023 $95 · 2024 $306 · 2025 $393
Food & beverage: $294Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $210 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $70 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| SHIELD THERAPEUTICS INC | 2 | $37 |
| Abbott Laboratories | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Veozah, GEMTESA, ACCRUFER, PROCLAIM, Mirena.
Industry payments across AL — which companies pay providers there.
